Eleonora Vecchio

Dr. Eleonora Vecchio


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2018 in Neurology
Verified
Journal Article
Open access
PDF file
CTCristina Tassorelli
Cristina Tassorelli
LGLicia Grazzi
Licia Grazzi
MTMarina de Tommaso
Marina de Tommaso
GPGiulia Pierangeli
Giulia Pierangeli
PMPaolo Martelletti
Paolo Martelletti
DMDaniela Di Maro
Daniela Di Maro
Objective To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute treatment of migraine in a multicenter, double-blind, randomized, sham-controlled trial. Methods A total of 248 participants with episodic migraine with/without aura were randomized to receive nVNS or sham within 20 minutes from pain onset. Participants were to repeat treatment if pain had not improved in 15 minutes. Results nVNS (n = 120) was superior to sham (n = 123) for pain freedom at 30 minutes (12.7% vs 4.2%; p = 0.012) and 60 minutes (21.0% vs 10.0%; p = 0.023) but not at 120 minutes (30.4% vs 19.7%; p = 0.067; primary endpoint; logistic regression) after the first treated attack. A post hoc repeated-measures test provided further insight into the therapeutic benefit of nVNS through 30, 60, and 120 minutes (odds ratio 2.3; 95% confidence interval 1.2, 4.4; p = 0.012). nVNS demonstrated benefits across other endpoints including pain relief at 120 minutes and was safe and well-tolerated. Conclusion This randomized sham-controlled trial supports the abortive efficacy of nVNS as early as 30 minutes and up to 60 minutes after an attack. Findings also suggest effective pain relief, tolerability, and practicality of nVNS for the acute treatment of episodic migraine. ClinicalTrials.gov identifier NCT02686034. Classification of evidence This study provides Class I evidence that for patients with an episodic migraine, nVNS significantly increases the probability of having mild pain or being pain-free 2 hours poststimulation (absolute difference 13.2%).

1 January 2011 in The Journal of Pain
Verified
Journal Article
Closed access
Marina De TommasoMarina De Tommaso
Marina De Tommaso
AFAntonio Federici
Antonio Federici
RSRoberto Santostasi
Roberto Santostasi
RCRita Calabrese
Rita Calabrese
EVEleonora Vecchio
Eleonora Vecchio
PLPaolo Livrea
Paolo Livrea

17 August 2011 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
Marina De TommasoMarina De Tommaso
Marina De Tommaso
AFAntonio Federici
Antonio Federici
CSClaudia Serpino
Claudia Serpino
EVEleonora Vecchio
Eleonora Vecchio
GFGiovanni Franco
Giovanni Franco
PLPaolo Livrea
Paolo Livrea
Our previous study assessed the prevalence of fibromyalgia (FM) syndrome in migraine and tension-type headache. We aimed to update our previous results, considering a larger cohort of primary headache patients who came for the first time at our tertiary headache ambulatory. A consecutive sample of 1,123 patients was screened. Frequency of FM in the main groups and types of primary headaches; discriminating factor for FM comorbidity derived from headache frequency and duration, age, anxiety, depression, headache disability, allodynia, pericranial tenderness, fatigue, quality of life and sleep, and probability of FM membership in groups; and types of primary headaches were assessed. FM was present in 174 among a total of 889 included patients. It prevailed in the tension-type headache main group (35%, p < 0.0001) and chronic tension-type headache subtype (44.3%, p < 0.0001). Headache frequency, anxiety, pericranial tenderness, poor sleep quality, and physical disability were the best discriminating variables for FM comorbidity, with 81.2% sensitivity. Patients presenting with chronic migraine and chronic tension-type headache had a higher probability of sharing the FM profile (Bonferroni test, p < 0.01). A phenotypic profile where headache frequency concurs with anxiety, sleep disturbance, and pericranial tenderness should be individuated to detect the development of diffuse pain in headache patients.

24 December 2013 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
Marina De TommasoMarina De Tommaso
Marina De Tommaso
MNMaria Nolano
Maria Nolano
Florenzo IannoneFlorenzo Iannone
Florenzo Iannone
EVEleonora Vecchio
Eleonora Vecchio
KRKatia Ricci
Katia Ricci
PLPaolo Livrea
Paolo Livrea

26 September 2014 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
Marina De TommasoMarina De Tommaso
Marina De Tommaso
marianna Delussimarianna Delussi
marianna Delussi
EVEleonora Vecchio
Eleonora Vecchio
VSvittorio sciruicchio
vittorio sciruicchio
Sara InvittoSara Invitto
Sara Invitto
PLPaolo Livrea
Paolo Livrea
Association between sleep disorders and headache is largely known. The aim of the present study was to evaluate sleep quality and quantity in a large cohort of primary headache patients, in order to correlate these scores with symptoms of central sensitization as allodynia, pericranial tenderness and comorbidity with diffuse muscle-skeletal pain.

1 December 2011 in Clinical Neurophysiology
Verified
Journal Article
Closed access
Marina De TommasoMarina De Tommaso
Marina De Tommaso
RSRoberto Santostasi
Roberto Santostasi
VDVito Devitofrancesco
Vito Devitofrancesco
GFGiovanni Franco
Giovanni Franco
EVEleonora Vecchio
Eleonora Vecchio
ZKZaza Katzarava
Zaza Katzarava